Arca
Skip to content
Tools
Tools

Essential tremor

Drug research and approvals for essential tremor: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 21, 2026, 60 studies of essential tremor are recruiting on ClinicalTrials.gov, and Health Canada has authorized 7 drug trials for it since 2013.

  • Recruiting worldwide: 60
  • Trials authorized in Canada: 7
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting now

Newest posted first, of 60 recruiting on ClinicalTrials.gov ↗

Drug pipeline

Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indications

Phase 3 2

Phase 2 12 of 17

Phase 1 or earlier 6

How its trials ended

223 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 36 whose ending is known, 28% met their primary endpoint, 6% missed it and 67% stopped early.

  • Completed, result not reported9944%
  • Ongoing5926%
  • Status unknown2913%
  • Stopped: other or unclear146%
  • Met its primary endpoint104%
  • Stopped: enrollment or feasibility63%
  • Stopped: sponsor or business decision42%
  • Missed its primary endpoint21%

Trials authorized in Canada

Newest first; search them all in Canada trials
Jun 18, 2026A phase 2b multicenter, randomized, double-blind, placebo-controlled study with an open-label period to evaluate the efficacy and safety of agn 151607 dp…AGN-151607-DP (gemibotulinumtoxina)AbbVieOngoing
Nov 5, 2021A phase 2 multicenter, randomized, double-blind, placebo-controlled study of botox® (botulinum toxin type a) purified neurotoxin complex for the treatment of…BotoxAbbVieClosed
Oct 19, 2021A phase 2, randomized, double-blind, placebo-controlled, dose range finding clinical trial to evaluate the tolerability, safety, and efficacy of PRAX-944 in…PRAX-944Praxis Precision MedicineOngoing
Mar 17, 2021A phase 2a, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety and pharmacokinetics of ES-481 in adult patients with essential…ES-481Es Therapeutics, Inc.Closed
Sep 28, 2018Assessment of safety and feasibility of exablate neuro system to perform auto-focusing echo imaging in patients with idiopathic essential tremor with…PerflutrenInsightecPending
Jun 26, 2015Use of kinematic assessment of hand tremor pre- and post-treatment with botulinum toxin type a in essential tremor and Parkinson diseaseXeominLawson Health Research InstituteOngoing
Jan 15, 2015Botulinum toxin type a for injection of bilateral upper extremity tremor in patients with essential tremor using kinematic assessmentXeomin (incobotulinumtoxina)Lawson Health Research InstitutePending

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.